Epidural Steroid Injections Tied to Small Surgery-Sparing Effect

This article originally appeared here.
Share this content:
Epidural Steroid Injections Tied to Small Surgery-Sparing Effect
Epidural Steroid Injections Tied to Small Surgery-Sparing Effect

MONDAY, Jan. 19, 2015 (HealthDay News) -- For patients with low back pain, epidural steroid injections (ESIs) could reduce the need for surgery, but the evidence is limited, according to research published in the Feb. 1 issue of The Spine Journal.

Mark C. Bicket, M.D., from Massachusetts General Hospital in Boston, and colleagues conducted a systematic review and meta-analysis to examine whether ESIs have a surgery sparing effect in patients with spinal pain. Data were included from 26 studies.

The researchers found that only those studies that assessed the effect of ESIs on the need for surgery as a primary outcome examined the same patient cohort; based on these studies, there was moderate evidence that patients receiving ESI versus control treatment were less likely to undergo surgery. For studies examining surgery as a secondary outcome, there was a trend toward reduction in the need for surgery for short-term (less than one year) outcomes (risk ratio, 0.68; 95 percent confidence interval, 0.41 to 1.13; P = 0.14), but not long-term (at least one year) outcomes (risk ratio, 0.95; 95 percent conduce interval, 0.77 to 1.19; P = 0.68). Low-level evidence was seen in secondary analyses suggesting that between one-third and one-half of patients considering surgery could avoid surgery with ESIs.

"Epidural steroid injections may provide a small surgery-sparing effect in the short term compared with control injections and reduce the need for surgery in some patients who would otherwise proceed to surgery," the authors write.

One author disclosed financial ties to the medical device and medical technology industries.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »